Novartis AG
Picolinic acid derivatives and their use as intermediates

Last updated:

Abstract:

The present invention relates to new picolinic acid derivatives of formula (I) and their use as intermediates in the process of making pyridine derivatives, including (S)-3-amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(tri- fluoromethyl)picolinamide that are useful for the treatment of respiratory disorders. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

18 Dec 2017

Issue date:

28 Apr 2020